COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey.

Singer, A J; Fuggle, N R; Gill, C B; Patel, A R; Medeiros, A P; Greenspan, S L

Singer, A J; Fuggle, N R; Gill, C B; Patel, A R; Medeiros, A P; Greenspan, S L.

Afiliação

Singer AJ; Departments of Medicine and Obstetrics and Gynecology, MedStar Georgetown University Hospital and Georgetown University Medical Center, Washington, DC, USA. andrea.f.singer@gunet.georgetown.edu.
Fuggle NR; Department of Obstetrics and Gynecology, MedStar Georgetown University Hospital, Washington, DC, USA. andrea.f.singer@gunet.georgetown.edu.
Gill CB; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
Patel AR; Alan Turing Institute, London, UK.
Medeiros AP; National Osteoporosis Foundation, Arlington, VA, USA.
Greenspan SL; National Osteoporosis Foundation, Arlington, VA, USA.

Osteoporos Int ; 32(4): 619-622, 2021 04.

Article em En | MEDLINE | ID: mdl-33558958

Assuntos

COVID-19; Osteoporose; Humanos; Osteoporose/tratamento farmacológico; SARS-CoV-2

Palavras-chave

Bone health; COVID-19; Fracture; Osteoporosis; Telemedicine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / COVID-19 Limite: Humans Idioma: En Revista: Osteoporos Int Assunto da revista: METABOLISMO / ORTOPEDIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google